Olema Pharmaceuticals, Inc. OLMA

Set alert

Price alert · OLMA

All alert types
7.07 USD +0.07 +1.00%

At close · Nov 2

7.07 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
7.05 × 2
Ask
7.06 × 2
6.71 Day range 7.13
6.24 52-week range 36.26
YTD
-71.72%
1 year
-21.18%
Open
7.00
Prev close
7.00
Mkt cap
618.61M
Vol
1.12M
Avg vol
1.19M
EPS
-2.12
P/E
0.00
Div yield
0.00%
More statistics
Low
6.71
High
7.13
Forward P/E
-4.86
Beta
2.01
Short ratio
7.94
Inst. own
118.48%
Dividend
0.00
Ex-div date
Earnings
Nov 10, 2026
50-d avg
11.34
200-d avg
17.51
1y target
40.70

MAX chart

Chart tools
Interval

Events in this range
  • Aug 11, 2025Earnings: -0.51; estimate -0.43; surprise -18.6%
  • Nov 10, 2025Earnings: -0.49; estimate -0.44; surprise -11.36%
  • Mar 16, 2026Earnings: -0.5; estimate -0.51; surprise 1.96%
  • Mar 17, 2026Rating: Guggenheim · Buy → Buy
  • Mar 17, 2026Rating: Citigroup · Buy → Buy
  • Mar 18, 2026Rating: Goldman Sachs · Buy → Buy
  • Mar 18, 2026Rating: JP Morgan · Overweight → Overweight
  • Mar 27, 2026Rating: Wolfe Research · — → Peer Perform
  • May 12, 2026Earnings: -0.52; estimate -0.52; surprise 0%
  • May 13, 2026Rating: Guggenheim · Buy → Buy
  • Aug 10, 2026Earnings: -0.61; estimate -0.55146; surprise -10.62%
Signals (110)
NameDateAgo
RSI: OversoldOct 12, 20263 weeks ago
MACD: Sell SignalSep 21, 20261 month ago
MACD: Buy SignalAug 31, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BearishJul 6, 20263 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BearishMar 9, 20267 months ago
MACD: Sell SignalFeb 9, 20268 months ago
SMA: BearishJan 19, 20269 months ago
SMA: BullishNov 17, 202511 months ago
RSI: OverboughtNov 17, 202511 months ago
SMA: BearishNov 3, 202512 months ago
SMA: BullishOct 27, 20251 year ago
SMA: BearishOct 20, 20251 year ago
RSI: OverboughtSep 29, 20251 year ago
SMA: BullishAug 11, 20251 year ago
SMA: BearishAug 4, 20251 year ago
SMA: BullishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishJul 7, 20251 year ago
SMA: BearishJun 2, 20251 year ago
SMA: BullishApr 14, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
RSI: OversoldMar 31, 20251 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BearishOct 21, 20242 years ago
SMA: BearishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BullishOct 7, 20242 years ago
SMA: BearishSep 30, 20242 years ago
MACD: Sell SignalSep 30, 20242 years ago
SMA: BearishSep 23, 20242 years ago
SMA: BullishSep 16, 20242 years ago
MACD: Buy SignalSep 9, 20242 years ago
MACD: Sell SignalSep 2, 20242 years ago
SMA: BearishAug 19, 20242 years ago
SMA: BullishAug 12, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BearishAug 5, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishJul 1, 20242 years ago
SMA: BearishJun 17, 20242 years ago
MACD: Buy SignalJun 10, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BullishJun 3, 20242 years ago
SMA: BearishMar 11, 20242 years ago
SMA: BearishMar 4, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BearishDec 4, 20232 years ago
MACD: Sell SignalDec 4, 20232 years ago
RSI: OverboughtOct 30, 20233 years ago
SMA: BullishOct 23, 20233 years ago
SMA: BearishOct 16, 20233 years ago
RSI: OverboughtOct 2, 20233 years ago
RSI: OverboughtSep 11, 20233 years ago
SMA: BullishAug 21, 20233 years ago
SMA: BearishAug 14, 20233 years ago
RSI: OverboughtAug 7, 20233 years ago
RSI: OverboughtJul 17, 20233 years ago
RSI: OverboughtJun 26, 20233 years ago
RSI: OverboughtMay 1, 20233 years ago
SMA: BullishApr 17, 20233 years ago
MACD: Buy SignalApr 17, 20233 years ago
SMA: BullishApr 10, 20233 years ago
MACD: Sell SignalApr 3, 20233 years ago
SMA: BearishMar 27, 20233 years ago
SMA: BearishMar 6, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BullishJan 2, 20233 years ago
SMA: BearishNov 28, 20223 years ago
SMA: BullishNov 21, 20223 years ago
SMA: BearishNov 14, 20223 years ago
SMA: BearishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BullishOct 17, 20224 years ago
SMA: BearishSep 12, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BullishAug 22, 20224 years ago
SMA: BearishAug 8, 20224 years ago
SMA: BearishAug 8, 20224 years ago
SMA: BullishJul 4, 20224 years ago
SMA: BullishMay 30, 20224 years ago
MACD: Buy SignalMar 7, 20224 years ago
RSI: OversoldNov 29, 20214 years ago
MACD: Sell SignalNov 22, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishOct 18, 20215 years ago
SMA: BearishOct 18, 20215 years ago
SMA: BullishOct 11, 20215 years ago
SMA: BullishOct 11, 20215 years ago
SMA: BearishOct 4, 20215 years ago
SMA: BullishAug 9, 20215 years ago
SMA: BearishJul 12, 20215 years ago
SMA: BullishJun 21, 20215 years ago
SMA: BearishJun 14, 20215 years ago
SMA: BullishJun 7, 20215 years ago
SMA: BearishMar 15, 20215 years ago
SMA: BullishMar 8, 20215 years ago
SMA: BearishFeb 22, 20215 years ago
SMA: BullishFeb 1, 20215 years ago

Financial health

Altman Z-Score

4.15 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 2

Valuation

P/E -13.4×
FY 2018: -306×FY 2019: -445×FY 2020: -82.9×FY 2021: -5.2×FY 2022: -0.9×FY 2023: -6.6×FY 2024: -2.6×FY 2025: -13.4×
FY 2018 5y median -5.2× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 4.5×
FY 2018: -110×FY 2019: -186×FY 2020: 5.6×FY 2021: 1.3×FY 2022: 0.5×FY 2023: 2.5×FY 2024: 0.8×FY 2025: 4.5×
FY 2018 5y median 1.3× FY 2025
P/FCF -14.8×
FY 2018: -317×FY 2019: -639×FY 2020: -94.9×FY 2021: -7.1×FY 2022: -1.2×FY 2023: -7.6×FY 2024: -3.3×FY 2025: -14.8×
FY 2018 5y median -7.1× FY 2025
EV/EBITDA -13.1×
FY 2018: -332×FY 2019: -457×FY 2020: -72.1×FY 2021: -5.1×FY 2022: -0.7×FY 2023: -5.9×FY 2024: -1.6×FY 2025: -13.1×
FY 2018 5y median -5.1× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -6.7%
FY 2018: -0.3%FY 2019: -0.2%FY 2020: -1.1%FY 2021: -14.1%FY 2022: -84.1%FY 2023: -13.2%FY 2024: -30.5%FY 2025: -6.7%
FY 2018 5y median -14.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -33.9%
FY 2018: 35.0%FY 2019: 40.7%FY 2020: -6.5%FY 2021: -25.0%FY 2022: -53.0%FY 2023: -38.1%FY 2024: -31.7%FY 2025: -33.9%
FY 2018 5y median -33.9% FY 2025
ROIC -37.0%
FY 2018: -67.7%FY 2019: 347.0%FY 2020: -6.4%FY 2021: -24.8%FY 2022: -53.5%FY 2023: -41.0%FY 2024: -34.7%FY 2025: -37.0%
FY 2018 5y median -37.0% FY 2025
ROA -30.5%
FY 2018: -67.2%FY 2019: -3269.7%FY 2020: -6.5%FY 2021: -24.0%FY 2022: -48.6%FY 2023: -34.9%FY 2024: -28.7%FY 2025: -30.5%
FY 2018 5y median -30.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -25.6%
FY 2018: 0.0%FY 2019: -107.9%FY 2020: -398.0%FY 2021: -232.1%FY 2022: -49.7%FY 2023: 1.9%FY 2024: -35.5%FY 2025: -25.6%
FY 2018 FY 2025
EPS (diluted) 15.0%
FY 2018: 0.0%FY 2019: 31.3%FY 2020: -427.3%FY 2021: -208.6%FY 2022: -46.4%FY 2023: 18.3%FY 2024: -2.8%FY 2025: 15.0%
FY 2018 FY 2025
Free Cash Flow -40.4%
FY 2018: 0.0%FY 2019: -41.6%FY 2020: -546.6%FY 2021: -162.3%FY 2022: -57.7%FY 2023: -1.6%FY 2024: -24.8%FY 2025: -40.4%
FY 2018 FY 2025

Financial Health

Current Ratio 10.0×
FY 2018: 16.1×FY 2019: 0.1×FY 2020: 74.6×FY 2021: 32.2×FY 2022: 12.6×FY 2023: 12.3×FY 2024: 10.5×FY 2025: 10.0×
FY 2018 5y median 12.3× FY 2025
Quick Ratio 10.0×
FY 2018: 16.1×FY 2019: 0.1×FY 2020: 74.6×FY 2021: 32.2×FY 2022: 12.6×FY 2023: 12.3×FY 2024: 10.5×FY 2025: 10.0×
FY 2018 5y median 12.3× FY 2025
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2018: 1.5×FY 2019: 0.0×FY 2020: 15.7×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.7×FY 2024: 1.1×FY 2025: 0.3×
FY 2018 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2018: -74.3×FY 2019: 0.0×FY 2020: -33.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31